Literature DB >> 21129986

Azido-iodo-N-benzyl derivatives of threo-methylphenidate (Ritalin, Concerta): Rational design, synthesis, pharmacological evaluation, and dopamine transporter photoaffinity labeling.

David J Lapinsky1, Ranganadh Velagaleti, Nageswari Yarravarapu, Yi Liu, Yurong Huang, Christopher K Surratt, John R Lever, James D Foster, Rejwi Acharya, Roxanne A Vaughan, Howard M Deutsch.   

Abstract

In contrast to <span class="Chemical">tropanen>-based compounds such as <span class="Chemical">benztropine and <span class="Chemical">cocaine, non-tropane-based photoaffinity ligands for the dopamine transporter (DAT) are relatively unexplored. Towards addressing this knowledge gap, ligands were synthesized in which the piperidine nitrogen of 3- and 4-iodomethylphenidate was substituted with a benzyl group bearing a photoreactive azide. Analog (±)-3a demonstrated modest DAT affinity and a radioiodinated version was shown to bind covalently to rat striatal DAT and hDAT expressed in cultured cells. Co-incubation of (±)-3a with nonradioactive d-(+)-methylphenidate or (-)-2-β-carbomethoxy-3-β-(4-fluorophenyl)tropane-CFT, WIN-35,428, a cocaine analog) blocked DAT labeling. Compound (±)-3a represents the first successful example of a DAT photoaffinity ligand based on the methylphenidate scaffold. Such ligands are expected to assist in mapping non-tropane ligand-binding pockets within plasma membrane monoamine transporters. Copyright Â
© 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21129986      PMCID: PMC3023924          DOI: 10.1016/j.bmc.2010.11.002

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  42 in total

Review 1.  Using photolabile ligands in drug discovery and development.

Authors:  G Dormán; G D Prestwich
Journal:  Trends Biotechnol       Date:  2000-02       Impact factor: 19.536

2.  Slow-onset, long-duration, alkyl analogues of methylphenidate with enhanced selectivity for the dopamine transporter.

Authors:  Mark Froimowitz; Yonghong Gu; Les A Dakin; Pamela M Nagafuji; Charles J Kelley; Damon Parrish; Jeffrey R Deschamps; Aaron Janowsky
Journal:  J Med Chem       Date:  2007-01-25       Impact factor: 7.446

Review 3.  New insights into the mechanism of action of amphetamines.

Authors:  Annette E Fleckenstein; Trent J Volz; Evan L Riddle; James W Gibb; Glen R Hanson
Journal:  Annu Rev Pharmacol Toxicol       Date:  2007       Impact factor: 13.820

4.  Dopamine transporter ligand binding domains. Structural and functional properties revealed by limited proteolysis.

Authors:  R A Vaughan; M J Kuhar
Journal:  J Biol Chem       Date:  1996-08-30       Impact factor: 5.157

5.  Asymmetric synthesis and pharmacology of methylphenidate and its para-substituted derivatives.

Authors:  D L Thai; M T Sapko; C T Reiter; D E Bierer; J M Perel
Journal:  J Med Chem       Date:  1998-02-12       Impact factor: 7.446

6.  Recognition of benztropine by the dopamine transporter (DAT) differs from that of the classical dopamine uptake inhibitors cocaine, methylphenidate, and mazindol as a function of a DAT transmembrane 1 aspartic acid residue.

Authors:  Okechukwu T Ukairo; Corry D Bondi; Amy Hauck Newman; Santosh S Kulkarni; Alan P Kozikowski; Stephen Pan; Christopher K Surratt
Journal:  J Pharmacol Exp Ther       Date:  2005-05-05       Impact factor: 4.030

Review 7.  Neurobiology of cocaine abuse.

Authors:  W L Woolverton; K M Johnson
Journal:  Trends Pharmacol Sci       Date:  1992-05       Impact factor: 14.819

8.  Synthesis and pharmacology of site-specific cocaine abuse treatment agents: restricted rotation analogues of methylphenidate.

Authors:  Deog-Il Kim; Howard M Deutsch; Xiaocong Ye; Margaret M Schweri
Journal:  J Med Chem       Date:  2007-05-10       Impact factor: 7.446

9.  In vivo characterization of a novel phenylisothiocyanate tropane analog at monoamine transporters in rat brain.

Authors:  Vishakantha Murthy; Thomas J Martin; Susy Kim; Huw M L Davies; Steven R Childers
Journal:  J Pharmacol Exp Ther       Date:  2008-05-20       Impact factor: 4.030

10.  Differential binding of tropane-based photoaffinity ligands on the dopamine transporter.

Authors:  R A Vaughan; G E Agoston; J R Lever; A H Newman
Journal:  J Neurosci       Date:  1999-01-15       Impact factor: 6.167

View more
  4 in total

1.  (±)-2-(N-tert-Butylamino)-3'-[(125)I]-iodo-4'-azidopropiophenone: a dopamine transporter and nicotinic acetylcholine receptor photoaffinity ligand based on bupropion (Wellbutrin, Zyban).

Authors:  David J Lapinsky; Shaili Aggarwal; Tammy L Nolan; Christopher K Surratt; John R Lever; Rejwi Acharya; Roxanne A Vaughan; Akash Pandhare; Michael P Blanton
Journal:  Bioorg Med Chem Lett       Date:  2011-11-04       Impact factor: 2.823

2.  Evolution of a Compact Photoprobe for the Dopamine Transporter Based on (±)-threo-Methylphenidate.

Authors:  David J Lapinsky; Nageswari Yarravarapu; Tammy L Nolan; Christopher K Surratt; John R Lever; Michael Tomlinson; Roxanne A Vaughan; Howard M Deutsch
Journal:  ACS Med Chem Lett       Date:  2012-03-11       Impact factor: 4.345

3.  Novel Azido-Iodo Photoaffinity Ligands for the Human Serotonin Transporter Based on the Selective Serotonin Reuptake Inhibitor (S)-Citalopram.

Authors:  Vivek Kumar; Nageswari Yarravarapu; David J Lapinsky; Danielle Perley; Bruce Felts; Michael J Tomlinson; Roxanne A Vaughan; L Keith Henry; John R Lever; Amy Hauck Newman
Journal:  J Med Chem       Date:  2015-07-08       Impact factor: 7.446

4.  Azidobupramine, an Antidepressant-Derived Bifunctional Neurotransmitter Transporter Ligand Allowing Covalent Labeling and Attachment of Fluorophores.

Authors:  Thomas Kirmeier; Ranganath Gopalakrishnan; Vanessa Gormanns; Anna M Werner; Serena Cuboni; Georg C Rudolf; Georg Höfner; Klaus T Wanner; Stephan A Sieber; Ulrike Schmidt; Florian Holsboer; Theo Rein; Felix Hausch
Journal:  PLoS One       Date:  2016-02-10       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.